154
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Glucoside Derivatives Of Podophyllotoxin: Synthesis, Physicochemical Properties, And Cytotoxicity

, , , , , , ORCID Icon, ORCID Icon & show all
Pages 3683-3692 | Published online: 23 Oct 2019

References

  • Gomes TRH, Fernando MH, Regnia CM. Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis. Int J Nanomedicine. 2018;13:2321–2336. doi:10.2147/ijn.s164355
  • Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod. 2003;66:1022–1037. doi:10.1021/np030096l12880330
  • Newman DJ. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem. 2008;51:2589–2599. doi:10.1021/jm070409018393402
  • Ojima I. Modern natural products chemistry and drug discovery. J Med Chem. 2008;51:2587–2588. doi:10.1021/jm701291u18393400
  • MacRae WD, Hudson JB, Towers BH. The antiviral action of lignans. Planta Med. 1989;55:531–535. doi:10.1055/s-2006-9620872559420
  • Umesha B, Basavaraju YB, Mahendra C. Synthesis and biological screening of pyrazole moiety containing analogs of podophyllotoxin. Med Chem Res. 2015;24:142–151. doi:10.1007/s00044-014-1100-3
  • You YJ. Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents. Curr Pharm Des. 2005;11:1695–1717. doi:10.2174/138161205376472415892669
  • Gordaliza M, Garcia PA, Miguel Del Corral JM, Castro MA, Gomez-Zurita MA. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon. 2004;44:441–459. doi:10.1016/j.toxicon.2004.05.00815302526
  • Lv M, Xu H. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010). Mini-Rev Med Chem. 2011;11:901–909. doi:10.2174/13895571179657546121781026
  • Zhang X, Rakesh KP, Shantharam CS, et al. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: a key current imminent needs. Bioorg Med Chem. 2018;26:340–355. doi:10.1016/j.bmc.2017.11.02629269253
  • Lee KH, Imakura Y, Haruna M, et al. Antitumor agents, 107. New cytotoxic 4-alkylamino analogues of 4ʹ-demethyl-epipodophyllotoxin as inhibitors of human DNA topoisomerase II. J Nat Prod. 1989;52:606–613. doi:10.1021/np50063a0212550587
  • Le KH, Beers SA, Mori M, et al. Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4ʹ-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II. J Med Chem. 1990;33:1364–1368. doi:10.1021/jm00167a0132158562
  • Wang ZQ, Kuo YH, Schnur D, et al. Antitumor agents. 113. New 4 beta-arylamino derivatives of 4ʹ-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II. J Med Chem. 1990;33:2660–2666. doi:10.1021/jm00171a0502167985
  • Jardine I. Podophyllotoxins In: Cassady JM, Douros JD, editors. Anticancer Agents Based on Natural Product Models. New York, NY, USA: Academic Press; 1980:319–351.
  • Reddy DM, Srinivas J, Chashoo G, Saxena AK, Sampath Kumar HM. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synhtesis and biological ecaluation. Eur J Med Chem. 2011;46:1983–1991. doi:10.1016/j.ejmech.2011.02.01621477899
  • Zi CT, Yang D, Dong FW, et al. Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives. Bioorg Med Chem. 2015;23:1437–1446. doi:10.1016/j.bmc.2015.02.02125744190
  • Zi CT, Liu ZH, Li GT, et al. Synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives. Molecules. 2015;20:3255–3280. doi:10.3390/molecules2002325525690288
  • Zi CT, Li GT, Li Y, et al. Synthesis and anticancer activity of 4β-triazole-podophyllotoxin glycosides. Nat Prod Bioprospect. 2015;5:83–90. doi:10.1007/s13659-015-0057-3
  • Zi CT, Xu FQ, Li GT, et al. Synthesis and anticancer activity of glucosylated podophyllotoxin derivatives linked via 4β-triazole rings. Molecules. 2013;18:13992–14012. doi:10.3390/molecules18111399224232736
  • Reddy PB, Paul DV, Agrawal SK, Saxena AK, Kumar HM, Qazi GN. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents. Arch Pharm. 2008;341:126–131. doi:10.1002/ardp.200700116
  • Stähelin HF, von Wartburg A. The chemical and biological route from podophyllotoxin glucoside to etoposide: ninth Cain memorial Award lecture. Cancer Res. 1991;51:5–15.1988106
  • Gu XY, Chen L, Wang X, et al. Direct glycosylation of bioactive small molecules with glycosyl iodide and strained olefin as acid scavenger. J Org Chem. 2014;3:1100–1110. doi:10.1021/jo402551x
  • Daley L, Guminski Y, Demerseman P, et al. Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611. J Med Chem. 1998;41:4475–4485. doi:10.1021/jm98007529804687
  • Allevi P, Anastasia M, Ciuffred P, Sanvito AM, Macdonald P. A short and simple synthesis of the antitumor agent etoposide. Tetrahedron Lett. 1992;33:4831–4834. doi:10.1016/S0040-4039(00)61297-2
  • Kuhn M, von Wartburg A. Über ein neues glykosidierungsverfahren synthese von epipodophyllotoxin-β-D-glucopyranosid. 21. Mitt. Über mitosehemmende Naturstoffe. Helv Chim Acta. 1968;51:1631–1641. doi:10.1002/hlca.196805107195688036
  • Cohen RB, Tsou KC, Rutenburg SH, Seligman AM. The colorimetric estimation and histochemical demonstration of beta-d-galactosidase. J Biol Chem. 1952;195:239–249.14938374
  • Kartha KP, Field RA. Iodine: a versatile reagent in carbohydrate chemistry IV. Per-O-acetylation, regioselective acylation and acetolysis. Tetrahedron. 1997;53:11753–11766. doi:10.1016/S0040-4020(97)00742-4
  • Fiandor J, García-López MT, De Las Heras FG, Méndez-Castrillón PP. A facile regioselective 1-O-deacylation of peracylated glycopyranoses. Synthesis. 1985;12:1121–1123. doi:10.1055/s-1985-31446
  • Hansen HF, Jesen RB, Willumsen AM, et al. New compounds related to podophyllotoxin and congeners: synthesis, structure elucidation and biological testing. Acta Chem Scand. 1993;47:1190–1200. doi:10.3891/acta.chem.scand.47-11908110531
  • Zi CT, Yang L, Gao W, et al. Click glycosylation for the synthesis of 1,2,3-triazole-linked picropodophyllotoxin glycoconjugates and their anticancer activity. ChemistrySelect. 2017;2:5038–5044. doi:10.1002/slct.201700347
  • Brewer CF, Loike JD, Horwitz SB, Sternlicht H, Gensler WJ. Conformational analysis of podophyllotoxin and its congeners. Structure-activity relationship in microtubule assembly. J Med Chem. 1979;22:215–221. doi:10.1021/jm00190a007423203
  • de Oliveira PF, Alves JM, Damasceno JL, Oliveira RAM, Dias HJ, Crotti AEM. Cytotoxicity screening of essential oils in cancer cell lines. Rev Bras Farmacogn. 2012;22:88–93.
  • Shi JF, Wu P, Jiang ZH, Wei XY. Synthesis and tumor cell growth inhibitory activity of biotinylated annonaceous acetogenins. Eur J Med Chem. 2014;71:219–228. doi:10.1016/j.ejmech.2013.11.01224308999
  • Malich G, Markovic B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology. 1997;124:179–192. doi:10.1016/s0300-483x(97)00144-39482120
  • Zamoiskii EA. Evaluation of Reed-Muench method in determination of activity of biological preparations. Zh Mikrobiol Epidemiol Immunobiol. 1956;27:77–83.
  • Stanic MA. simplification of the estimation of the 50 percent endpoints according to the Reed and Muench method. Pathologia Et Microbiologia (basel). 1963;26:298–302.
  • Jeong YC, Anwar M, Moloney MG. Synthesis, antibiotic activity and structure–activity relationship study of some 3-enaminetetramic acids. Bioorg Med Chem Lett. 2014;24:1190–1200. doi:10.1016/j.bmcl.2014.03.013
  • Hartwell JL, Schrecker AW. Components of Podophyllin V. The Constitution of Podophyllotoxin. J Am Chem Soc. 1951;73:2909–2916. doi:10.1021/ja01150a143